Health Canada has the duty to make sure drugs approved for sale are safe. Yet crucial information from clinical trials is often kept from the Canadian public, as “confidential business information” or “trade secrets.”
Sep 7, 2011
Globe and Mail
http://www.theglobeandmail.com/news/opinions/editorials/drug-trials-should-not-be-information-inhibitors/article2157156/
Sep 7, 2011
Globe and Mail
http://www.theglobeandmail.com/news/opinions/editorials/drug-trials-should-not-be-information-inhibitors/article2157156/
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment